CYP1A1 and non-small cell lung carcinoma: In an Australian study to identify lung cancer-risk modifying CYP1A1 haplotypes, *2A and *2C variants were significantly over-represented in NSCLC cases compared to controls, whereas *4 variant was under-represented.